C
IBB icon

Certuity’s iShares Biotechnology ETF IBB Stock Holding History

Certuity’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Sell
2,732
-18
-0.7% -$3.09K 0.03% 326
2026
Q1 		$464K Buy
2,750
+249
+10% +$42.6K 0.03% 311
2025
Q4 		$422K Sell
2,501
-25
-1% -$4.06K 0.03% 312
2025
Q3 		$365K Buy
2,526
+1
+0% +$136 0.03% 340
2025
Q2 		$319K Buy
2,525
+27
+1% +$3.31K 0.03% 285
2025
Q1 		$319K Sell
2,498
-937
-27% -$127K 0.03% 251
2024
Q4 		$454K Buy
+3,435
New +$483K 0.05% 188
2024
Q3 		– Sell
-2,194
Closed -$301K – 371
2024
Q2 		$301K Sell
2,194
-638
-23% -$85.2K 0.02% 261
2024
Q1 		$389K Sell
2,832
-595
-17% -$81.3K 0.03% 198
2023
Q4 		$466K Buy
+3,427
New +$418K 0.05% 189
2022
Q4 		– Sell
-4,369
Closed -$511K – 225
2022
Q3 		$511K Buy
+4,369
New +$543K 0.12% 85

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Certuity's IBB Position: Q2 2026 in Review

Certuity reduced its iShares Biotechnology ETF (IBB) stake by 0.65% in Q2 2026, selling an estimated $3.09K and leaving 2,732 shares worth $520K. The position accounts for 0.03% of the portfolio, ranked #326.

Certuity first reported a position in IBB in Q3 2022 and has held it in 11 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Certuity held 2,732 shares of iShares Biotechnology ETF worth $520K as of Q2 2026.
  • Certuity sold 18 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.09K.
  • iShares Biotechnology ETF made up 0.03% of Certuity's portfolio in Q2 2026, its #326 holding.
  • Certuity first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 11 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.